Adaptive Biotechnologies Insider Sells After Doubling Rally
When a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Concise guidance on identifying budgeting flaws early and applying simple corrections to avoid debt and build security.
24,706 articlesWhen a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Vornado Realty Trust CEO Steven Roth used a quarterly earnings call to harshly rebuke New York City's tax agenda, cal...
As AI accelerates, investors face a long-term choice between NVDA and AMD. This piece weighs profitability, growth, a...
Global oil inventories are near eight-year lows as tensions around Iran raise the risk of supply disruption. Prices h...
Google’s Gemini AI released a bold Solana forecast, pairing a performance upgrade roadmap with a price trajectory tha...
Bitcoin and Ethereum ETFs faced renewed selling pressure as prices struggled to push through key resistance. ETF flow...
A 62-year-old facing five years before Social Security may need $800,000 to $1.14 million in investable assets to gen...
Investors have watched quantum stocks climb even amid mixed news. This guide explains the forces fueling the rally, h...
The AI revolution is just getting started, and a few names stand out as strong, long-term bets. This guide highlights...
A JPMorgan forecast suggests the S&P 500 could rise about 22% from current levels to roughly 9,000 by mid-2027, led b...
Investors are seeing renewed momentum in xanadu quantum technologies stock as talk of government support and industry...
Investors are watching Bionano Genomics as the company enters 2026 with evolving demand for optical genome mapping. T...